About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 138 record(s)
Req # A-2020-001059
Please provide the number of units of Decitabine 50 mg/vial allowed for entry into Canada via the Special Access Program from January 1, 2012 to November 1, 2020.Organization: Health Canada
November 2020
Req # A-2018-001448
Adverse Reaction Reports (AERs) for PETHIDINE HYDROCHLORIDE. Report numbers: E2B_01755077, E2B_01802868.Organization: Health Canada
November 2020
Req # A-2018-001798
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 18-075681-361.Organization: Health Canada
November 2020
Req # A-2019-000603
Adverse Reaction Reports (AERs) for Pantoprazole. Report numbers: E2B_02264829, E2B_02369267, E2B_02299849, E2B_02309078, E2B_02310500, E2B_02320494, E2B_02333000, E2B_02338563, E2B_02277090, E2B_02301569, E2B_02368200, E2B_02369848, E2B_02369970, 721604.Organization: Health Canada
November 2020
Req # A-2019-001305
Adverse Reaction Report (AER). Report number: 000729201.Organization: Health Canada
November 2020
Req # A-2019-001338
Adverse Reaction Reports (AERs). Report numbers: E2B_02538688, E2B_02479897, E2B_02350595.Organization: Health Canada
November 2020
Req # A-2019-001650
Adverse Reaction Reports (AERs) for PETHIDINE HYDROCHLORIDE. Report numbers: E2B_02472669, E2B_02299746, E2B_02299752, E2B_02319004, E2B_02330669, E2B_02413750, E2B_02432443, E2B_02461571, E2B_02470293, E2B_02430181, E2B_02433031.Organization: Health Canada
November 2020
Req # A-2019-001667
Adverse Reaction Report (AER). Report number: E2B_02559490.Organization: Health Canada
November 2020
Req # A-2019-001669
Adverse Reaction Report (AER). Report number: E2B_02564654.Organization: Health Canada
November 2020
Req # A-2019-001736
Adverse Reaction Reports (AERs) for ONDANSETRON. Report numbers: E2B_02774286, E2B_02774323, 2B_02791878.Organization: Health Canada
November 2020